Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IRWD Ironwood Pharmaceuticals

Watchlist
11.400
-0.140-1.21%
Close  02/03 16:00 ET
11.4000.0000.00%
Post Mkt Price 02/03 16:04 ET
High
11.695
Open
11.490
Turnover
26.08M
Low
11.310
Pre Close
11.540
Volume
2.28M
Market Cap
1.75B
P/E(TTM)
12.26
52wk High
12.950
Shares
153.40M
P/E(Static)
3.55
52wk Low
9.730
Float Cap
1.53B
Bid/Ask %
0.00%
Historical High
21.200
Shs Float
134.42M
Volume Ratio
1.27
Historical Low
7.350
Dividend TTM
--
Div Yield TTM
--
P/B
2.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.70%
Amplitude
3.34%
Avg Price
11.428
Lot Size
1
Float Cap
1.53B
Bid/Ask %
0.00%
Historical High
21.200
Shs Float
134.42M
Volume Ratio
1.27
Historical Low
7.350
Dividend TTM
--
P/B
2.96
Dividend LFY
--
Turnover Ratio
1.70%
Amplitude
3.34%
Avg Price
11.428
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need, leveraging demonstrated expertise and capabilities in GI diseases. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.
CEO: Mr. Thomas A. McCourt
Market: NASDAQ
Listing Date: 02/03/2010
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist